About
Soliddd is an optical and vision technology company that has developed the world's first low-vision aid for macular degeneration that actually provides sight to those areas of the visual field where users previously have been blind.
We began years ago with inventions based on our unique understanding of the physics of autostereo 3D. Eventually our optics led us to discover a way that the human visual cortex can perceive 3D, which we can use to treat a number of conditions.
We are now in pre-clinical testing. So far, every single qualified subject with macular degeneration that we have tested has seen their reading speed increase by a factor of at least 50%, and most have seen many times that improvement.
Team
Neal Weinstock
CEO
Motti Attia
Director, Business Development
.jpg)
Michael Silbergleid
VP, Marketing & Communications
Richard A. Muller
Chief Science Officer
Raffaello Galby
VP, Operations
Graham Stubbs
Lead Programmer
Al Schubert
SVP, Sales
Jay Hirschson
CFO
Medical Advisory Board
Our Medical Advisory Board includes seven of the leading experts in their respective disciplines. These experts each brings a unique skillset to Soliddd to make sure that our technology benefits both the body and mind.
Michael S. Berlin, M.D., M.Sc., FAAO is the inventor of excimer laser technology. He is Founder & Director of Glaucoma Institute of Beverly Hills and EyeLight Innovations, Inc. He is a Professor of Clinical Ophthalmology, UCLA Stein Eye Institute and an active member of AGS, AAO, ASCRS, and ASLMS.
Georgia Crozier, O.D., M.S. is an optometrist, low vision specialist, and the Chief Medical Officer of Moore Eye Institute’s Low Vision Rehabilitation Center. She was the first optometrist selected by the federal government to receive a Masters of Science in Vision Rehabilitation. Dr. Crozier has lectured extensively and is a facilitator for low vision support groups.
Susan Malinowski, M.D. is a retinologist who is dedicated to education and advancements in vitreo-retinal disease. She is the author of numerous articles and lectures extensively, both nationally and internationally. She has completed original research to advance the development of low cost, alternative treatments for blinding eye diseases. She scored first in the nation on the Ophthalmology National Board Examination.
William H. Seiple, Ph.D. is Chief Research Officer at Lighthouse Guild; Research Professor of Ophthalmology at NYU School of Medicine; Adjunct Faculty, Aging in Vision and Action Team, Institut de la Vision; and Visiting Professor at the Université Pierre-et-Marie-Curie, Paris, France.
Janet P. Szlyk, Ph.D. is President and CEO of The Chicago Lighthouse, and is a highly respected researcher and scientist in the field of low vision. In 2020, the National Federation of the Blind of Illinois honored Dr. Szlyk’s commitment to developing job opportunities for people who are blind or visually impaired with its prestigious Ilene O’Brien Memorial Award.
Sonya Vieira, M.D. is a Psychiatrist and Psychoanalyst with over 20-years of experience caring for her patients. She is Board Certified in Adult Psychiatry and Fellowship-trained in Child & Adolescent Psychiatry. In her practice, she also offers psychoanalytically-informed psychotherapy with or without medication.
Bryan Wolynski, O.D., FAAO is the Chief of Vision Rehabilitation at Cleveland Sight Center, where he leads clinical and rehabilitation programs supporting people with vision loss across the lifespan. He has extensive experience in low vision rehabilitation and assistive technology integration into daily life. He has presented on these subjects nationally, internationally, and at the United Nations.
Media Contacts
Henry Feintuch / Doug Wright
Feintuch Communications
914-548-6924 / 201-952-6033